US 7070959
Modified chimeric polypeptides with improved pharmacokinetic properties
granted A61KA61K38/00A61P
Quick answer
US patent 7070959 (Modified chimeric polypeptides with improved pharmacokinetic properties) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/00, A61P, A61P43/00